Journal
AUTOIMMUNITY REVIEWS
Volume 15, Issue 9, Pages 917-922Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.autrev.2016.07.007
Keywords
B cell; Regulatory T cell; TGF-beta; Integrin
Categories
Funding
- AbbVie
- Astellas
- BMS
- Daiichi-Sankyo
- MitsubishiTanabe
- Pfizer
- Sanofi
- Santen
- Takeda
- Teijin
- Boehringer Ingelheim
- Chugai
- Eisai
- Ono
- Taisho Toyama
- UCB
- ImmunoFuture
- Asahi Kasei
- Janssen
Ask authors/readers for more resources
TGF-beta family members are multipotent cytokines that are involved in many cellular processes, including cell differentiation, organ development, wound healing and immune regulation. TGF-beta has pleiotropic effects on adaptive immunity, especially in the regulation of CD4(+) T cell and B cell responses. Furthermore, identification of CD4(+) T cell subsets that produce TGF-beta 3 revealed unexpected roles of TGF-beta 3 in the control of adaptive immunity. In contrast to TGF-beta 1, which induces extensive fibrosis, TGF-beta 3 induces non-scarring wound healing and counteracts tissue fibrosis. Recent progress in the understanding of the activation mechanism of TGF-beta may enable us to develop novel biologic therapies based on advanced protein engineering. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available